ClinicalTrials.gg
Active, not recruitingNCT07905742Updated Nov 2, 2026

Effects of Scapular Stabilization on Rotator Cuff Strength, Shoulder Pain, and Function

An interventional study of Scapular Stabilization and Conventional treatment in Shoulder Pain and Stiffness, sponsored by University of Management and Technology Lahore. Active, not recruiting at 1 site in Pakistan. Open to participants aged 25 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by University of Management and Technology Lahore · Not applicable, Interventional, and Treatment

Updated Nov 2, 2026Title changedNewly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
25 Years to 45 Years
Sex
All
01

Study summary

The goal of this control trail is to describe the effects of scapular stabilization exercises on rotator cuff strength, shoulder pain and function in physiotherapist. There is effect of scapular stabilization exercises on on rotator cuff strength, shoulder pain and function in physiotherapist. Experimental Group: Participants will ask to do the scapualar stabilization exercises with conventional treatment for 40 mins for 6 weeks for 3 days each week. Participants will recive conventional treatment for 40 mins and ask to do their routine work and rest for the 6 weeks, 3 days each week.

02

Conditions studied

  • Shoulder Pain and Stiffness

Keywords

  • pain
  • function
  • rotator cuff
  • strength
  • exercises
03

In context

Shoulder Pain

735 studies on the registry are indexed under Shoulder Pain; 167 are open to participants now.

This study's enrollment of 34 is below the median of 60 across 587 interventional studies indexed under Shoulder Pain.

Browse Shoulder Pain studies →

Lead sponsor

University of Management and Technology Lahore is the lead sponsor of 39 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Registered physiotherapists of either gender, aged 25 to 45 years
  • Shoulder pain for at least four weeks with a Numeric Pain Rating Scale score of 3 or higher
  • Positive Hawkins-Kennedy test, defined as reproduction of the participant's usual shoulder pain.
  • Currently working 6 to 8 clinical hours per week.

Exclusion criteria

Exclusion Criteria:

  • Previous history of shoulder surgery, fracture or dislocation
  • Suspected full-thickness rotator cuff tear (positive drop arm test or lag signs), frozen shoulder or cervical radiculopathy
  • Neurological disorders or systemic inflammatory conditions
  • injection in the shoulder within the past three months
  • Currently receiving any other treatment for the shoulder
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
34 participants (actual)

Study arms

  • Experimental
    Scapular Stabilization Exercises

    Other: Scapular Stabilization

  • Placebo comparator
    Conventional Treatment

    Other: Conventional treatment

Interventions

  • OtherScapular Stabilization

    A supervised scapular stabilization program delivered for six weeks, three sessions per week, along with conventional treatment lasting about 30 to 40 minutes. Each session will include: Warm-up (5 minutes) Scapular retraction and depression exercises Prone horizontal abduction and prone Y, T and W exercises Serratus anterior strengthening (wall slides, push-up plus) The program will be progressed by increasing repetitions (for example, from 2 sets of 10 to 3 sets of 15)

  • OtherConventional treatment

    This Group will receive conventional treatment for six weeks three sessions per week, lasting for 20 minutes. Participants will continue their usual activities and receive general advice on posture and work ergonomics. Conventional Treatment: 15 minutes of hot pack with TENS with frequency (100 HZ) and intensity 10mA.

06

What researchers measure

Primary outcomes

  1. Numeric Pain Rating Scale

    11-point numeric with 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform)

    Time frame: Baseline and after 6 weeks

  2. Hand Held Dynamometer

    Rotator cuff strength will be measured with a handheld dynamometer (microFET2) using the make-test method, in which the participant pushes maximally against the device while the examiner holds it stationary. External and internal rotation will be tested with the participant seated, the arm at the side with a small towel roll under the elbow and the elbow flexed to 90°, with the device placed just proximal to the wrist on the posterior and anterior surfaces of the forearm, respectively. Scaption strength will be tested with the arm elevated to approximately 90° in the scapular plane with the thumb pointing upward, and the device placed on the upper surface of the forearm just above the wrist.

    Time frame: Baseline and after 6 weeks

  3. Shoulder Pain and Disability Index

    Shoulder pain and function will be assessed with the Shoulder Pain and Disability Index (SPADI), a self-administered 13-item questionnaire. It has a five-item pain subscale and an eight-item disability subscale, each item rated from 0 (no pain or difficulty) to 10 (worst pain or so difficult that help is needed). Each subscale is converted to a percentage, and the total score is the mean of the two (0 to 100), with higher scores indicating greater pain and disability.

    Time frame: Baseline and after 6 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — The results data collected; de-identified individual participant data will be shared.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: 6 months after the publication of the manuscript.

Access criteria: The data can be requested from the corresponding author.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Dec 2026, 2 months after the start.

Of 349 non-industry interventional studies with no phase under Shoulder Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's planned 2 months is below that.

Counting every sponsor, half of 354 studies reached it within 11 months; a quarter within 4 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 23, 2026
First posted
Oct 29, 2026
StartActual
Oct 23, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Title
Effects of Scapular Stabilization on Rotator Cuff Strength, Shoulder Pain, Ansdand Function
Nov 2, 2026
Registered
First appeared on the registry
Oct 29, 2026
Show all 2 updates
  1. Nov 2, 2026
    Title Effects of Scapular Stabilization on Rotator Cuff Strength, Shoulder Pain, Ansdand Function
    + 1 other change: criteria formatting
  2. Oct 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07905742
Lead sponsor
University of Management and Technology Lahore
Responsible party
Ayesha Karim (Dr. Ayesha Karim, Lecturer, University of Management and Technology Lahore) — Principal investigator
First posted
Oct 29, 2026
Start date
Oct 23, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 2, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion